510(k) device
Single Use Ureteral Access Sheath
Zhejiang Chuangxiang Medical Technology Co., Ltd. · Endoscopic Access Overtube, Gastroenterology-Urology (FED, Class II) · First FDA decision May 25, 2022, newest Sep 11, 2026Kidney stones
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
10
Naming "Single Use Ureteral"
MAUDE reports
0
Brand "Single Use Ureteral", since 2015
PubMed studies
0
Mentioning "Single Use Ureteral"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Single Use Ureteral Access Sheath
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K260410 · Decided Sep 11, 2026 · 214 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Single Use Ureteral", any status and sponsor, newest update first.
Calyxo, Inc.Not on our public-company list
NCT07155005 · 1,000 participants (planned) · Start Oct 12, 2026 · Primary completion Dec 2028
Device: CVAC® SYSTEM; FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS) and 1 more · For: Urolithiasis; Stones, Kidney; Renal Stones and 1 more
Sites: Miami, Florida; Wichita, Kansas; Cheektowaga, New York · 10 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Single Use Ureteral", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FED
605 reports: 419 malfunction, 169 injury, 15 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Single Use Ureteral"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FED.
- Pathfinder Endoscope OvertubeNeptune Medical, Inc. · 510(k) 2026
- Navigator HD Ureteral Access Sheath Set 11/13 F x 28cm (M0062502210)Boston Scientific Corporation · 510(k) 2025
- Re-Trace Ureteral Access Sheath, 12/14 Ch/Fr, Length 35 Cm, Length 45 CmColoplast A/S · 510(k) 2014
- CVAC Aspiration SystemCalyxo, Inc. · 510(k) 2026
- Single-use Ureteral Access SheathHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2025
- ClearPetra Suction-Evacuation SheathWell Lead Medical Co., Ltd. · 510(k) 2020
- Arc EndoCuff and Arc EndoCuff VisionBoddingtons Plastics, Ltd. · 510(k) 2016
- Barosense Endogastric Tube and Introducer BougieBarosense, Inc. · 510(k) 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.